Prostate Cancer and Immune Monitoring: Are We Heading Towards Better Selection of Patients and Treatment Strategies?
- PMID: 27544581
- DOI: 10.1016/j.eururo.2016.08.014
Prostate Cancer and Immune Monitoring: Are We Heading Towards Better Selection of Patients and Treatment Strategies?
Comment on
-
Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.Eur Urol. 2017 May;71(5):776-787. doi: 10.1016/j.eururo.2016.07.033. Epub 2016 Aug 3. Eur Urol. 2017. PMID: 27497761
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical